-
1
-
-
0021691705
-
Natural history of choroidal neovascularization in degenerative myopia
-
Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984;91:1573-1581.
-
(1984)
Ophthalmology
, vol.91
, pp. 1573-1581
-
-
Avila, M.P.1
Weiter, J.J.2
Jalkh, A.E.3
Trempe, C.L.4
Pruett, R.C.5
Schepens, C.L.6
-
2
-
-
0020575945
-
Visual prognosis of disciform degeneration in myopia
-
Hampton GR, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983;90:923-926.
-
(1983)
Ophthalmology
, vol.90
, pp. 923-926
-
-
Hampton, G.R.1
Kohen, D.2
Bird, A.C.3
-
3
-
-
0033507014
-
Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization
-
Tabandeh H, Flynn HW Jr, Scott IU, et al. Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 1999;106:2063-2067.
-
(1999)
Ophthalmology
, vol.106
, pp. 2063-2067
-
-
Tabandeh, H.1
Flynn Jr, H.W.2
Scott, I.U.3
-
4
-
-
0036209618
-
Long-term visual prognosis of choroidal neovascularization in high myopia: A comparison between age groups
-
Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 2002;109: 712-719.
-
(2002)
Ophthalmology
, vol.109
, pp. 712-719
-
-
Yoshida, T.1
Ohno-Matsui, K.2
Ohtake, Y.3
-
5
-
-
0035038772
-
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial - VIP report no. 1
-
Verteporfin in Photodynamic Therapy Study Group
-
Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-852.
-
(2001)
Ophthalmology
, vol.108
, pp. 841-852
-
-
-
6
-
-
0242500327
-
Verteporfin therapy of subfoveal choroidal neovascularisation in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no. 3
-
Verteporfin in Photodynamic Therapy (VIP) Study Group
-
Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularisation in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no. 3. Ophthalmology 2003;110:667-673.
-
(2003)
Ophthalmology
, vol.110
, pp. 667-673
-
-
-
7
-
-
0037309939
-
Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation
-
Montero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003;87:173-176.
-
(2003)
Br J Ophthalmol
, vol.87
, pp. 173-176
-
-
Montero, J.A.1
Ruiz-Moreno, J.M.2
-
8
-
-
33745782355
-
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
-
Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2006;26:495-511.
-
(2006)
Retina
, vol.26
, pp. 495-511
-
-
Rich, R.M.1
Rosenfeld, P.J.2
Puliafito, C.A.3
-
9
-
-
35348944795
-
Intravitreal bevacizumab (Avastin) as primary treatment for myopic cho-roidal neovascularization
-
Mandal S, Venkatesh P, Sampangi R, Garg S. Intravitreal bevacizumab (Avastin) as primary treatment for myopic cho-roidal neovascularization. Eur J Ophthalmol 2007;17:620-626.
-
(2007)
Eur J Ophthalmol
, vol.17
, pp. 620-626
-
-
Mandal, S.1
Venkatesh, P.2
Sampangi, R.3
Garg, S.4
-
10
-
-
34447324654
-
Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia
-
Hernandez-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, et al. Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina 2007;27:707-712.
-
(2007)
Retina
, vol.27
, pp. 707-712
-
-
Hernandez-Rojas, M.L.1
Quiroz-Mercado, H.2
Dalma-Weiszhausz, J.3
-
11
-
-
67749085482
-
-
Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, et al. Intravit-reous bevacizumab to treat subfoveal choroidal neovascular-ization in highly myopic eyes: short-term results. Eye 2007. [epub ahead of print].
-
Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, et al. Intravit-reous bevacizumab to treat subfoveal choroidal neovascular-ization in highly myopic eyes: short-term results. Eye 2007. [epub ahead of print].
-
-
-
-
12
-
-
33846828813
-
Intravitreal Avastin for choroidal neovascularisation in pathological myopia: The controversy continues
-
Rosenfeld PJ. Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues. Br J Ophthalmol 2007;91:128-130.
-
(2007)
Br J Ophthalmol
, vol.91
, pp. 128-130
-
-
Rosenfeld, P.J.1
-
13
-
-
33846783133
-
Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
-
Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol 2007;91:157-160.
-
(2007)
Br J Ophthalmol
, vol.91
, pp. 157-160
-
-
Yamamoto, I.1
Rogers, A.H.2
Reichel, E.3
Yates, P.A.4
Duker, J.S.5
-
14
-
-
33846785427
-
Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia
-
Sakaguchi H, Ikuno Y, Gomi F, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 2007;91: 161-165.
-
(2007)
Br J Ophthalmol
, vol.91
, pp. 161-165
-
-
Sakaguchi, H.1
Ikuno, Y.2
Gomi, F.3
-
15
-
-
36549066793
-
Intravitreal bevaci-zumab (Avastin) for myopic choroidal neovascularization. Six-month results of a prospective pilot study
-
Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevaci-zumab (Avastin) for myopic choroidal neovascularization. Six-month results of a prospective pilot study. Ophthalmology 2007;114:2190-2196.
-
(2007)
Ophthalmology
, vol.114
, pp. 2190-2196
-
-
Chan, W.M.1
Lai, T.Y.2
Liu, D.T.3
Lam, D.S.4
-
16
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
-
(2006)
N Engl J Med
, vol.355
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
-
17
-
-
33144456714
-
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization
-
Tong JP, Chan WN, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006;141:456 -462.
-
(2006)
Am J Ophthalmol
, vol.141
, pp. 456-462
-
-
Tong, J.P.1
Chan, W.N.2
Liu, D.T.3
|